Advanced cholangiocarcinoma is associated with a poor prognosis despite standard platinum-based chemotherapy. Recently, the ...
Primary cutaneous T‑cell lymphomas (CTCLs) represent a heterogenous group of lymphomas that manifest within the skin, without any extracutaneous involvement at the initial diagnosis [ 1 ]. This ...
Primary central nervous system (CNS) tumors pose significant challenges due to their heterogeneous nature, frequently limited prognosis, and substantial impact on quality of life. Despite advances in ...
At ASCO 2025, several promising studies in pancreatic ductal adenocarcinoma (PDAC) were presented. In the neoadjuvant setting, the CASSANDRA trial compared the PAXG (nab-paclitaxel, capecitabine, ...
Neoadjuvant therapy plays an increasingly important role in the multidisciplinary management of gastrointestinal cancers.
Neoadjuvant therapy (NAT) for early breast cancer was first introduced in the 1980s to downstage large, inoperable tumors, ...
Recent data presented at ASCO 2025 highlighted important advances in the treatment of ovarian cancer. The results of three ...
Dr. Sarah Temkin ist Regisseurin und Produzentin von 1001 Cuts. Als gynäkologische Onkologin mit über zwanzig Jahren ...
Beim chronischen Unterbauchschmerz kommt es regelmäßig zu Schmerzen, die im Becken wahrgenommen werden. Wir berichten über ...
Esophageal cancer poses a major health concern in the US, representing 1% of all cancer diagnoses and 2.6% of cancer-related deaths, with an estimated 21,560 new cases and 16,120 deaths in 2023 [ 1 – ...
Die Aorta erzählt ihre eigene Geschichte – von kindlicher Reinheit über die ersten molekularen Irritationen bis hin zum ...
Lasse Rehné Jensen, M.D. Dunja Kokotovic, M.D. Ph.D Jakob Burcharth, M.D. Ph.D Sup. Fig. 1 Separate response rates for all questionnaires at each timepoint for the before and after groups. All ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback